Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidney of Gentamicin-, Mercury-, or Chromium-Treated Rats: Relationship to Renal Distributions of iNOS and Nitrotyrosine

Immunohistochemical studies for kidney injury molecule-1 (Kim-1), renal papillary antigen-1 (RPA-1), and renal papillary antigen-2 (RPA-2) were conducted to explore their relationship to inducible nitric oxide synthase (iNOS) and nitrotyrosine expression. Male Sprague-Dawley rats were exposed to gentamicin (100 mg/kg/day Gen, sc, for 3 days), mercury (0.25 mg Hg/kg, iv, single dose), or chromium (5 mg Cr/kg, sc, single dose) and kidney tissue was examined 24 hours or 72 hours after the last dose of the nephrotoxicant. Another group of kidneys was evaluated 24 hours after rats were administered 3 daily doses (50, 100, 150, 200, or 300 mg/kg/day) of Gen. Gen- and Cr-treated rats exhibited increased immunoreactivity of Kim-1, RPA-1, and RPA-2 largely in the S1/S2 segments and to a lesser extent in the S3 segments of the proximal tubule of the kidney, whereas Hg-treated rats showed increased immunoreactivity of Kim-1, RPA-1, and RPA-2 in the S3 segments. Up-regulation of Kim-1, RPA-1, and RPA-2 expression correlated with injured tubular epithelial cells and also correlated with immunoreactivity of iNOS and nitrotyrosine. It is possible that iNOS activation with nitrotyrosine production in injured nephron segments may be involved in the induction of Kim-1, RPA-1, and RPA-2 following exposure to nephrotoxicants.

[1]  B. Rosenzweig,et al.  Age‐related differences in susceptibility to cisplatin‐induced renal toxicity , 2009, Journal of applied toxicology : JAT.

[2]  J. Bonventre,et al.  Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. , 2008, Kidney international.

[3]  Jun Zhang,et al.  The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  M. C. V. D. Heuvel,et al.  Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.

[5]  Ximing J. Yang,et al.  Human Kidney Injury Molecule-1 (hKIM-1): A Useful Immunohistochemical Marker for Diagnosing Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma , 2007, The American journal of surgical pathology.

[6]  Martin Shaw,et al.  Histologically defined biomarkers in toxicology , 2007, Expert opinion on drug safety.

[7]  H. van Goor,et al.  Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. , 2007, Kidney international.

[8]  P. Cristofori,et al.  Renal Proximal Tubule Segment-Specific Nephrotoxicity: An Overview on Biomarkers and Histopathology , 2007, Toxicologic pathology.

[9]  Joseph V Bonventre,et al.  Mechanistic biomarkers for cytotoxic acute kidney injury , 2006, Expert opinion on drug metabolism & toxicology.

[10]  S. Bakker,et al.  Tubular kidney injury molecule-1 in protein-overload nephropathy. , 2006, American journal of physiology. Renal physiology.

[11]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[12]  M. Takaoka,et al.  RETRACTION: Opposite Effects of Pre- and Postischemic Treatments with Nitric Oxide Donor on Ischemia/Reperfusion-Induced Renal Injury , 2006, Journal of Pharmacology and Experimental Therapeutics.

[13]  Joseph V Bonventre,et al.  Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.

[14]  N. Rifai,et al.  Mechanisms and Biomarkers of Cardiovascular Injury Induced by Phosphodiesterase Inhibitor III SK&F 95654 in the Spontaneously Hypertensive Rat , 2006, Toxicologic pathology.

[15]  M. Faghihi,et al.  Effects of nitric oxide on gentamicin toxicity in isolated perfused rat kidneys. , 2005, Journal of nephrology.

[16]  J. Pedraza-Chaverri,et al.  Time course study of oxidative and nitrosative stress and antioxidant enzymes in K2Cr2O7-induced nephrotoxicity , 2005, BMC nephrology.

[17]  H. Parlakpınar,et al.  Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. , 2005, Toxicology.

[18]  Rafael Radi,et al.  Nitric oxide, oxidants, and protein tyrosine nitration , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Bonventre,et al.  Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .

[20]  Timothy A Bertram,et al.  Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.

[21]  J. Pedraza-Chaverri,et al.  Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats. , 2003, Life sciences.

[22]  Paul L Huang,et al.  Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse Kidney* , 2003, Journal of Biological Chemistry.

[23]  Sudhir V. Shah,et al.  Apoptotic pathways of oxidative damage to renal tubular epithelial cells. , 2002, Antioxidants & redox signaling.

[24]  S. Somlo,et al.  Kidney injury molecule-1 expression in murine polycystic kidney disease. , 2002, American journal of physiology. Renal physiology.

[25]  Merlin C. Thomas,et al.  Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. , 2002, Diabetes.

[26]  T. Yokozawa,et al.  Potential of Sanguiin H-6 against Oxidative Damage in Renal Mitochondria and Apoptosis Mediated by Peroxynitrite in vivo , 2002, Nephron.

[27]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[28]  M. Goligorsky,et al.  Nitric oxide in acute renal failure: NOS versus NOS. , 2002, Kidney international.

[29]  Debasis Bagchi,et al.  Chromium (VI)‐induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene , 2001, Molecular and Cellular Biochemistry.

[30]  M. Yaqoob,et al.  Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. , 2000, Kidney international.

[31]  S. Shah,et al.  Oxidant mechanisms in toxic acute renal failure. , 1999, Drug metabolism reviews.

[32]  F. Murad,et al.  Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. , 1999, American journal of physiology. Renal physiology.

[33]  G. Schlüter,et al.  Urinary antigens as markers of papillary toxicity. II: Application of monoclonal antibodies for the determination of papillary antigens in rat urine , 1999, Archives of Toxicology.

[34]  F. Park,et al.  Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. , 1999, American journal of physiology. Renal physiology.

[35]  O. Wada,et al.  Inducible nitric oxide synthase expression in mercury chloride-induced acute tubular necrosis. , 1998, Industrial health.

[36]  R. Nemenoff,et al.  Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. , 1998, Kidney international.

[37]  Joseph V. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.

[38]  G. Diamond,et al.  Understanding Renal Toxicity of Heavy Metals , 1998, Toxicologic pathology.

[39]  S. Bachmann,et al.  Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. , 1997, Hypertension.

[40]  Division on Earth Guide for the Care and Use of Laboratory Animals , 1996 .

[41]  K. Ahn,et al.  In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. , 1994, The American journal of physiology.

[42]  N. Holstein-Rathlou,et al.  Effect of cisplatin on proximal convoluted and straight segments of the rat kidney. , 1988, The Journal of pharmacology and experimental therapeutics.

[43]  S. Sternberg,et al.  The renal pathology in clinical trials of Cis‐platinum (II) diamminedichloride , 1977, Cancer.

[44]  Ronald P. Brown,et al.  Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[46]  R. D. de Boer,et al.  Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. , 2007, American journal of physiology. Renal physiology.

[47]  Martin Shaw The use of histologically defined specific biomarkers in drug development with special reference to the glutathione S-transferases. , 2005, Cancer Biomarkers.

[48]  G. Daugaard,et al.  Cisplatin nephrotoxicity , 2004, Cancer Chemotherapy and Pharmacology.

[49]  T. Billiar,et al.  Role of NO and Nitrogen Intermediates in Regulation of Cell Functions , 1997 .

[50]  S. Bachmann Distribution of NOSs in the Kidney , 1997 .

[51]  G. Schlüter,et al.  Urinary antigens as markers of papillary toxicity. I Identification and characterization of rat kidney papillary antigens with monoclonal antibodies , 1996, Archives of Toxicology.

[52]  K. Meyer,et al.  Cisplatin nephrotoxicity. , 1994, Mineral and electrolyte metabolism.

[53]  S. Gambaryan,et al.  Age dependent differences in the functional and morphological impairment of kidney following cisplatin administration. , 1990, Experimental pathology.

[54]  N. Holstein-Rathlou,et al.  Functional and histopathological changes in dog kidneys after administration of cisplatin. , 1987, Renal physiology.